These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8573427)

  • 1. Skeletal safety of tiludronate.
    Neer RM
    Bone; 1995 Nov; 17(5 Suppl):501S-503S. PubMed ID: 8573427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral tiludronate: pharmacological properties and potential usefulness in Paget's disease of bone and osteoporosis.
    Reginster JY
    Bone; 1992; 13(5):351-4. PubMed ID: 1419375
    [No Abstract]   [Full Text] [Related]  

  • 3. Tiludronate. A new treatment for an old ailment: Paget's disease of bone.
    Morales-Piga A
    Expert Opin Pharmacother; 1999 Nov; 1(1):157-70. PubMed ID: 11249559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tiludronate: bone pharmacology and safety.
    Bonjour JP; Ammann P; Barbier A; Caverzasio J; Rizzoli R
    Bone; 1995 Nov; 17(5 Suppl):473S-477S. PubMed ID: 8573421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the bisphosphonate tiludronate on bone resorption, calcium balance, and bone mineral density.
    Ammann P; Rizzoli R; Caverzasio J; Shigematsu T; Slosman D; Bonjour JP
    J Bone Miner Res; 1993 Dec; 8(12):1491-8. PubMed ID: 8304051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bisphosphonates. A neu therapy principle in calcium and bone metabolism disorders].
    Raue F
    Internist (Berl); 1999 Apr; 40(4):448-55. PubMed ID: 10354947
    [No Abstract]   [Full Text] [Related]  

  • 7. Bisphosphonates: an overview with special reference to alendronate.
    Vasikaran SD
    Ann Clin Biochem; 2001 Nov; 38(Pt 6):608-23. PubMed ID: 11732644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic use of bisphosphonates.
    Compston JE
    BMJ; 1994 Sep; 309(6956):711-5. PubMed ID: 7950525
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular mechanisms of action of bisphosphonates.
    Rogers MJ; Frith JC; Luckman SP; Coxon FP; Benford HL; Mönkkönen J; Auriola S; Chilton KM; Russell RG
    Bone; 1999 May; 24(5 Suppl):73S-79S. PubMed ID: 10321934
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of Paget's disease].
    Kurth AA
    Orthopade; 2007 Feb; 36(2):118, 120-3. PubMed ID: 17252256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of drugs for Paget's disease of bone.
    Reginster JY; Lecart MP
    Bone; 1995 Nov; 17(5 Suppl):485S-488S. PubMed ID: 8573423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiludronate therapy for Paget's disease of bone.
    McClung MR; Tou CK; Goldstein NH; Picot C
    Bone; 1995 Nov; 17(5 Suppl):493S-496S. PubMed ID: 8573425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of idiopathic hyperphosphatasia with intensive bisphosphonate therapy.
    Cundy T; Wheadon L; King A
    J Bone Miner Res; 2004 May; 19(5):703-11. PubMed ID: 15068492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates for Paget's disease of bone in adults.
    Corral-Gudino L; Tan AJ; Del Pino-Montes J; Ralston SH
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD004956. PubMed ID: 29192423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable efficacy of bone remodeling biochemical markers in the management of patients with Paget's disease of bone treated with tiludronate.
    de la Piedra C; Rapado A; Díaz Diego EM; Díaz Martín MA; Aguirre C; López Gavilanes E; Díaz Curiel M
    Calcif Tissue Int; 1996 Aug; 59(2):95-9. PubMed ID: 8687976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of bisphosphonates].
    Nakatsuka K
    Nihon Rinsho; 2003 Feb; 61(2):219-25. PubMed ID: 12638211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Paget's disease--taming the wild osteoclast.
    Deftos LJ
    N Engl J Med; 2005 Sep; 353(9):872-5. PubMed ID: 16135831
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute effects of bisphosphonates on new and traditional markers of bone resorption.
    Pedrazzoni M; Alfano FS; Gatti C; Fantuzzi M; Girasole G; Campanini C; Basini G; Passeri M
    Calcif Tissue Int; 1995 Jul; 57(1):25-9. PubMed ID: 7671161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental basis for the use of bisphosphonates in Paget's disease of bone.
    Fleisch H
    Clin Orthop Relat Res; 1987 Apr; (217):72-8. PubMed ID: 3549097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tiludronate for Paget's disease of bone.
    Med Lett Drugs Ther; 1997 Jul; 39(1005):65-6. PubMed ID: 9255236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.